Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (161-170 of 234) with videos related to

Pageof 24
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2015
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell TransplantationRyan W Jacobs, Rima M Saliba, Koji Sasaki, et al.
Leukemia & Lymphoma|July 9, 2019
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 yearsQaiser Bashir, Kamal Chamoun, Denái R Milton, et al.
Bone Marrow Transplantation|July 9, 2020
Can we cure refractory Hodgkin's lymphoma with transplantation?Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
American Journal of Hematology|December 15, 2018
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndromeNeeraj Y Saini, Romil D Patel, Ankur Varma, et al.
Haematologica|August 19, 2021
Melphalan dose intensity for autologous stem cell transplantation in multiple myelomaSamer A Srour, Denái R Milton, Qaiser Bashir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Transplantation and Cellular Therapy|November 19, 2024
Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]Mansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|December 12, 2022
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell TransplantationMansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|July 12, 2023
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell TransplantationFevzi F Yalniz, Uri Greenbaum, Oren Pasvolsky, et al.
Pageof 24

Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2015
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell TransplantationRyan W Jacobs, Rima M Saliba, Koji Sasaki, et al.
Leukemia & Lymphoma|July 9, 2019
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 yearsQaiser Bashir, Kamal Chamoun, Denái R Milton, et al.
Bone Marrow Transplantation|July 9, 2020
Can we cure refractory Hodgkin's lymphoma with transplantation?Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
American Journal of Hematology|December 15, 2018
Long-term durable efficacy of autologous stem cell transplantation in POEMS syndromeNeeraj Y Saini, Romil D Patel, Ankur Varma, et al.
Haematologica|August 19, 2021
Melphalan dose intensity for autologous stem cell transplantation in multiple myelomaSamer A Srour, Denái R Milton, Qaiser Bashir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Transplantation and Cellular Therapy|November 19, 2024
Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]Mansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|December 12, 2022
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell TransplantationMansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|July 12, 2023
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell TransplantationFevzi F Yalniz, Uri Greenbaum, Oren Pasvolsky, et al.
Pageof 24